Latest filing published 07 Jul 2018 for RISE Life Science Corp., €6,524.
No signal scores available.
This profile gathers the share dealings of Robert Arthur Lelovic in RISE Life Science Corp. We count 3 filings; the first trade dates from 2 March 2018 and the latest from 29 June 2018.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
Most recently, on 7 July 2018, the filings show a transaction worth €6,524 in RISE Life Science Corp. Filings reach the SEDI feed a median of 8 days after the trade. This delay matters because a trade only becomes useful information once it is public. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations